Efficient derivation of stable primed pluripotent embryonic stem cells from bovine blastocysts.
Yanina Soledad BogliottiJun WuMarcela VilarinoDaiji OkamuraDelia Alba SotoCuiqing ZhongMasahiro SakuraiRafael Vilar SampaioKeiichiro SuzukiJuan Carlos Izpisua BelmontePablo Juan RossPublished in: Proceedings of the National Academy of Sciences of the United States of America (2018)
Embryonic stem cells (ESCs) are derived from the inner cell mass of preimplantation blastocysts. From agricultural and biomedical perspectives, the derivation of stable ESCs from domestic ungulates is important for genomic testing and selection, genome engineering, and modeling human diseases. Cattle are one of the most important domestic ungulates that are commonly used for food and bioreactors. To date, however, it remains a challenge to produce stable pluripotent bovine ESC lines. Employing a culture system containing fibroblast growth factor 2 and an inhibitor of the canonical Wnt-signaling pathway, we derived pluripotent bovine ESCs (bESCs) with stable morphology, transcriptome, karyotype, population-doubling time, pluripotency marker gene expression, and epigenetic features. Under this condition bESC lines were efficiently derived (100% in optimal conditions), were established quickly (3-4 wk), and were simple to propagate (by trypsin treatment). When used as donors for nuclear transfer, bESCs produced normal blastocyst rates, thereby opening the possibility for genomic selection, genome editing, and production of cattle with high genetic value.
Keyphrases
- gene expression
- embryonic stem cells
- genome editing
- crispr cas
- signaling pathway
- genome wide
- dna methylation
- copy number
- single cell
- endothelial cells
- stem cells
- risk assessment
- cell proliferation
- climate change
- heavy metals
- epithelial mesenchymal transition
- human health
- pi k akt
- wastewater treatment
- rna seq
- endoplasmic reticulum stress
- combination therapy
- pluripotent stem cells
- induced apoptosis
- kidney transplantation